RecruitingNot ApplicableNCT07032545

Metabotyping of Broccoli Microgreen in Obese Breast Cancer Survivors

Metabotyping of a Functional Food, Broccoli Microgreen, in Obese Breast Cancer Survivors


Sponsor

University of Maryland, Baltimore

Enrollment

24 participants

Start Date

Dec 3, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Obesity can pose significant challenges to maintaining long-term health in cancer survivors by increasing their risk of cancer coming back. Eating a healthy diet is an important way to help manage weight and improve overall health. Broccoli microgreens (BMG) are young broccoli plants packed with nutrients, and research suggests they may help prevent cancer. Previous studies in mice showed that BMG can improve gut health and metabolism, leading to better health outcomes in obese animals. This study will test whether BMG can be a useful addition to the diet of obese breast cancer (BC) survivors who have a higher risk of their cancer returning. 24 obese BC survivors will be invited to eat one serving (one cup, \~57 gram) of fresh BMG every day for two weeks. This will help understand if people can stick to this diet, how their bodies respond, and whether it affects metabolism and inflammation-two key factors linked to cancer risk. Biological markers such as body fat, glucose and lipids as well as gut bacterial changes will be analyzed to see how BMG affects individual health. This study may help create new diet strategies to improve health, reduce cancer risk, and support long-term recovery in cancer patients who are overweight or obese. In the future, this research could help doctors personalize nutrition plans to better support cancer survivors.


Eligibility

Sex: FEMALE

Plain Language Summary

Simplified for easier understanding

This study investigates whether eating broccoli microgreens (young sprouted broccoli plants) affects the body differently depending on a person's metabolic profile — in women who have survived breast cancer and are living with obesity. **You may be eligible if...** - You are a woman - You have been diagnosed with breast cancer (Stage I–III) - You completed curative treatment (surgery, chemo, and/or radiation) 2 to 60 months ago - Your BMI is over 30 (classified as obese) - You are willing to avoid other cruciferous vegetables (like broccoli, cabbage, kale) during the study **You may NOT be eligible if...** - You have gastrointestinal conditions or other health issues that prevent you from eating the intervention food - You are still in active cancer treatment - You are not a breast cancer survivor Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBroccoli microgreen (BMG)

All participants will consume one serving size (one cup, \~57 gram) of raw BMG daily for 2-week period of time.


Locations(1)

Breast Evaluation and Treatment Program, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center

Baltimore, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07032545


Related Trials